Public Profile

Adare Pharma Solutions

Adare Pharma Solutions, headquartered in the United States, is a leading provider in the pharmaceutical industry, specialising in advanced drug delivery systems and formulation development. Founded in 2014, the company has rapidly established itself as a key player in the market, with a focus on enhancing the bioavailability and stability of complex molecules. With operational facilities across North America and Europe, Adare Pharma Solutions offers a diverse range of services, including customised formulation development, manufacturing, and packaging solutions. Their unique expertise in oral and topical dosage forms sets them apart, enabling clients to bring innovative therapies to market efficiently. Recognised for their commitment to quality and innovation, Adare Pharma Solutions has achieved significant milestones, positioning themselves as a trusted partner for pharmaceutical companies seeking to optimise their product offerings.

DitchCarbon Score

How does Adare Pharma Solutions's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

18

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

19

Industry Benchmark

Adare Pharma Solutions's score of 18 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.

52%

Adare Pharma Solutions's reported carbon emissions

Adare Pharma Solutions, headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their climate impact or initiatives. However, the pharmaceutical industry is increasingly focusing on sustainability and reducing carbon footprints, indicating a potential for future commitments. As the sector evolves, it is expected that companies like Adare Pharma Solutions will adopt more robust climate strategies and transparency in emissions reporting.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Adare Pharma Solutions's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Adare Pharma Solutions is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Adare Pharma Solutions is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero

Similar Organizations

Frontage Laboratories, Inc.

US
Chemicals nec
Updated about 1 month ago
DitchCarbon Score

Recipharm

SE
Chemicals nec
Updated 1 day ago

Aenova Group GmbH

DE
Real estate services (70)
Updated about 1 month ago
DitchCarbon Score

Quotient Sciences Limited

GB
Research and development services (73)
Updated 20 days ago

Pharmaceutics International, Inc.

US
Chemicals nec
Updated about 1 month ago
DitchCarbon Score

Avara Pharmaceutical Services, Inc.

US
Chemicals nec
Updated 20 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers